M. J. Alves et al. / Tetrahedron 63 (2007) 11167–11173
11171
subjected to dry flash chromatography [pet. ether (3)/ether
(1)] giving an yellow oil (1.04 g; 2.45 mmol; 41.5%). H
(Ar), 131.9 (Ar), 134.2 (Ar), 149.5 (C-4), 157.4 (CO-ox),
196.9 (CO). IR (Nujol mull) nmax (cmꢁ1) 3062, 2962,
2887, 1753, 1664, 1584. HRMS (ESI) calcd 507.1315
[M+1]; found 507.131.
1
NMR (CDCl3, 300 MHz) dH¼0.19 (s, 3H, Me), 0.20 (s,
3H, Me), 0.94 (s, 9H, 3ꢂMe), 2.10 (s, 1H, H-7), 2.41 (s,
1H, H-7), 2.68 (dd, J¼0.9, 18.0 Hz, 1H, H-5), 2.94 (dm,
J¼18.0 Hz, 1H, H-5), 4.85 (t, J¼2.1 Hz, 1H, H-3), 5.10 (d,
J¼12.3 Hz, 1H, CH2Ph), 5.29 (d, J¼12.3 Hz, 1H, CH2Ph),
6.10 (br s, 1H, H-2), 6.30 (dd, J¼1.8, 2.4 Hz, 1H, Py),
7.35 (s, 5H), 7.59 (d, J¼2.1 Hz, 1H, Py), 7.62 (d,
J¼2.1 Hz, 1H, Py). 13C NMR (CDCl3, 75.5 MHz)
dC¼ꢁ4.6 (Me), ꢁ4.4 (Me), 17.9 (C), 25.5 (Me), 27.1 (C-
5), 30.0 (C-7), 39.4 (C-6), 65.8 (CH2Ph), 72.2 (C-2), 97.6
(C-3), 105.9 (CH, Py), 128.2 (CH), 128.3 (CH), 128.5
(CH), 128.7 (CH), 135.5 (C), 140.1 (CH, Py), 149.2 (C-4),
171.1 (CO). IR (neat) nmax (cmꢁ1) 3054, 2986, 1739.
HRMS (ESI) calcd 448.2032 [M+Na]; found 448.2027.
4.4. Treatment of the cycloadducts 3 and 4 with tetra-
butylammonium fluoride
4.4.1. Synthesis of pyridines 5.
4.4.1.1. Synthesis of methyl 1-(2,6-dichlorobenzyl)-4-
oxo-1,4-dihydro-pyridine-2-carboxylate 5a. To a solution
of cycloadduct 3a (233 mg; 0.46 mmol) in ACN (5 mL) was
added Bu4N+Fꢁ in THF (1 M, 146 mL, 0.15 mmol;
0.32 equiv) at 0 ꢀC. The reaction mixture was stirred for
2 h at rt. The solvent was evaporated, DCM (10 mL) was
added and then a multiple washing with water (3ꢂ15 mL)
was carried out. The organic layers were combined and dried
over MgSO4. The solvent was removed to afford a yellow oil
that spontaneously crystallize (54 mg; 0.17 mmol; 37%); mp
4.3.4. Synthesis of (4-(tert-butyldimethylsilyloxy)-7-
ethyl-2-(1H-pyrazol-1-yl)-1-aza-bicyclo[4.1.0]hept-3-en-
6-yl)(phenyl)methanone 3d. a-Azido acrylate 1d (0.54 g;
2.69 mmol) was solubilized in dry toluene (20 mL) and
heated under reflux for 3 h. The solution was concentrated
to half of its volume and diene I (0.53 g; 2.12 mmol) was
added. The reaction mixture was stirred for 4 days at rt.
The solvent was removed and the crude oil was subjected
to dry flash chromatography (silica; pet. ether/ether; polarity
gradient) to give the product as a yellow oil. Yield (0.52 g;
1
119–121 ꢀC. H NMR (CDCl3, 300 MHz) dH¼3.98 (s, 3H,
Me), 5.64 (s, 2H, CH2), 6.33 (dd, J¼3.0, 7.8 Hz, 1H, H-5),
6.94 (d, J¼3.0 Hz, 1H, H-3), 7.11 (d, J¼7.8 Hz, 1H, H-6),
7.31 (dd, J¼6.6, 9.3 Hz, 1H, Ar), 7.43–7.40 (m, 2H, Ar).
13C NMR (CDCl3, 75.5 MHz) dC¼51.1 (CH2), 53.5 (Me),
119.8 (CH, C-5), 122.0 (CH, C-3), 129.1 (CH, Ar), 131.3
(CH, Ar), 136.8 (C), 140.5 (C-6), 140.9 (C-2), 163.3 (CO),
178.5 (CO, C-4). IR (Nujol mull) nmax (cmꢁ1) 1748, 1625,
1558, 1537. HRMS (ESI) calcd 312.0194 [M+1]; found
312.0192.
1
1.23 mmol; 58%). H NMR (CDCl3, 300 MHz) dH¼0.18
(s, 3H, Me), 0.22 (s, 3H, Me), 0.38 (t, 3H, Me), 0.67–0.80
(m, 1H, CH2Me), 0.93 (s, 9H, 3ꢂMe), 1.41–1.56 (m, 1H,
CH2Me), 2.47 (dt, J¼2.4, 17.7 Hz, 1H, H-5), 2.50–2.56 (m,
1H, H-7), 2.90 (d, J¼17.7 Hz, 1H, H-5), 5.06 (t, J¼2.1 Hz,
1H, H-3), 6.30 (dd, J¼1.8, 2.1 Hz, 1H, Py), 6.35 (br s, 1H,
H-2), 7.48 (t, J¼8.1 Hz, 2H, Ar), 7.53–7.60 (m, 2H,
Py+Ar), 8.02 (d, J¼8.1 Hz, 1H, Py). 13C NMR (CDCl3,
75.5 MHz) dC¼ꢁ4.5 (Me), ꢁ4.3 (Me), 10.5 (Me), 17.9
(C), 23.9 (CH2), 25.5 (Me), 29.2 (C-5), 42.1 (C-7), 50.3 (C-
6), 72.0 (C-2), 98.8 (C-3), 106.0 (CH, Py), 128.6 (CH),
128.8 (CH), 129.5 (CH), 133.4 (CH, Py), 135.2 (C), 139.9
4.4.1.2. Synthesis of methyl 1-(4-methylbenzyl)-4-oxo-
1,4-dihydro-pyridine-2-carboxylate 5b. To a solution of
cycloadduct 3b (0.24 g; 0.55 mmol) in ACN (13 mL) was
added Bu4N+Fꢁ in THF (1 M; 550 mL; 0.55 mmol) at
0 ꢀC. The reaction mixture was stirred for 1 h at rt. The sol-
vent was evaporated, DCM (15 mL) was added and then
a multiple washing with water (3ꢂ15 mL) was carried out.
The organic layers were combined and dried over MgSO4.
The solvent was removed and a yellow oil was obtained
(54 mg; 0.21 mmol; 38%). 1H NMR (CDCl3, 300 MHz)
dH¼2.33 (s, 3H, Me), 3.80 (s, 1H, Me), 5.30 (s, 2H, CH2),
6.44 (dd, J¼3.0, 7.5 Hz, 1H, H-5), 6.91 (d, J¼3.0 Hz, 1H,
H-3), 6.99 (d, J¼7.8 Hz, 2H, Ar), 7.15 (d, J¼7.8 Hz, 2H,
Ar), 7.43 (d, J¼7.8 Hz, 2H, H-6). 13C NMR (CDCl3,
75.5 MHz) dC¼21.1 (Me), 53.3 (Me), 57.4 (CH2), 119.4
(CH, C-5), 122.5 (CH, C-3), 127.1 (CH, Ph), 129.7 (CH,
Ph), 132.3 (C, Ph), 138.5 (C, Ph), 140.0 (C-2), 143.2 (C-
(CH, Py), 148.8 (C-4), 197.1 (CO). IR (neat) nmax (cmꢁ1
)
3062, 2960, 2931, 2886, 2859, 1677, 1580, 1579, 1514.
HRMS (ESI) calcd 446.2240 [M+Na]; found 446.2234.
4.3.5. Synthesis of 3-(6-(4-bromobenzoyl)-4-(tert-butyldi-
methylsilyloxy)-7-methyl-1-aza-bicyclo[4.1.0]hept-3-en-
2-yl)oxazolidin-2-one 4e. To a solution of diene II (0.27 g;
1.0 mmol) in toluene (15 mL) was added azirine 2e (0.28 g;
1.0 mmol) and the resulting mixture was stirred at rt for
3 days under nitrogen. The solvent was removed to give
a crude oil, which was subjected to dry flash chromato-
graphy (silica; pet. ether/diethyl ether; polarity gradient) to
afford the adduct as a yellow solid (0.25 g; 0.50 mmol;
50%); mp 135–137 ꢀC. 1H NMR (CDCl3, 300 MHz)
dH¼0.16 (s, 3H, Me), 0.18 (s, 3H, Me), 0.91 (s, 9H,
3ꢂMe), 1.09 (d, J¼6.0 Hz, 3H, Me), 2.41 (dm,
J¼17.7 Hz, 1H, H-5), 2.50 (q, J¼6.0 Hz, 1H, H-7), 2.82
(d, J¼17.7 Hz, 1H, H-5), 3.62 (t, J¼7.8 Hz, 2H, CH2ox),
4.38 (m, 2H, CH2ox), 4.62 (t, J¼1.8 Hz, 1H, H-3), 5.86
(br s, 1H, H-2), 7.63 (d, J¼7.8 Hz, 2H, Ar), 7.94 (d,
J¼7.8 Hz, 2H, Ar). 13C NMR (CDCl3, 75.5 MHz)
dC¼ꢁ4.6 (Me), ꢁ4.4 (Me), 15.1 (Me), 17.9 (C), 25.5
(Me), 29.2 (C-5), 34.6 (C-7), 41.4 (CH2ox), 47.2 (C-6),
62.1 (CH2ox), 65.6 (C-2), 98.1 (C-3), 128.8 (Ar), 131.1
6), 162.9 (CO), 178.8 (CO, C-4). IR (neat) nmax (cmꢁ1
)
3395, 3028, 2955, 2925, 1738, 1632, 1567, 1515. HRMS
(ESI) calcd 258.1130 [M+1]; found 258.1126.
4.4.1.3. Synthesis of ethyl 2-(4-oxo-2-(pyridin-2-yl)-
pyridin-1(4H)-yl)acetate 5f. To a solution of adduct 4f
(0.16 g; 0.36 mmol) in ACN (5 mL) was added Bu4N+Fꢁ
in THF (1.0 M, 124 mL; 0.32 equiv) at 0 ꢀC. The resulting
mixture was stirred at rt for 2 h. DCM (20 mL) was added,
the organic phase washed with H2O (3ꢂ15 mL), dried
with MgSO4 and solvent removed to afford an oil contami-
nated with the reagent ammonium salt. The crude was dis-
solved in Et2O (20 mL) and washed with H2O (20 mL).
The aqueous phase was extracted with DCM (3ꢂ10 mL).
The organic layers were combined, dried over MgSO4 and
evaporated to give the pure title pyrimidone 5f as a yellow